Go Pro
→ Barricks gold output fell from 2 million ounces to 719000 (From Golden Portfolio) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Azenta, Inc. stock logo
AZTA
Azenta
$33.33
+4.0%		$25.62
$15.93
▼
$41.73
$1.54B1.37931,014 shs866,943 shs
CryoPort, Inc. stock logo
CYRX
CryoPort
$14.82
-2.0%		$15.49
$7.51
▼
$16.89
$750.63M1.89591,107 shs614,761 shs
Personalis, Inc. stock logo
PSNL
Personalis
$14.50
+2.4%		$12.39
$4.42
▼
$16.39
$1.52B2.272.57 million shs4.21 million shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$18.35
+0.2%		$17.86
$11.09
▼
$21.01
$371.13M1.32393,532 shs195,009 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Azenta, Inc. stock logo
AZTA
Azenta
0.00%+13.90%+26.34%+78.50%+10.37%
CryoPort, Inc. stock logo
CYRX
CryoPort
0.00%+0.20%-6.49%+14.81%+100.00%
Personalis, Inc. stock logo
PSNL
Personalis
0.00%+11.85%+0.64%+144.98%+213.97%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
0.00%+0.49%+0.44%+24.71%+29.29%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Azenta, Inc. stock logo
AZTA
Azenta
$33.33
+4.0%		$25.62
$15.93
▼
$41.73
$1.54B1.37931,014 shs866,943 shs
CryoPort, Inc. stock logo
CYRX
CryoPort
$14.82
-2.0%		$15.49
$7.51
▼
$16.89
$750.63M1.89591,107 shs614,761 shs
Personalis, Inc. stock logo
PSNL
Personalis
$14.50
+2.4%		$12.39
$4.42
▼
$16.39
$1.52B2.272.57 million shs4.21 million shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$18.35
+0.2%		$17.86
$11.09
▼
$21.01
$371.13M1.32393,532 shs195,009 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Azenta, Inc. stock logo
AZTA
Azenta
0.00%+13.90%+26.34%+78.50%+10.37%
CryoPort, Inc. stock logo
CYRX
CryoPort
0.00%+0.20%-6.49%+14.81%+100.00%
Personalis, Inc. stock logo
PSNL
Personalis
0.00%+11.85%+0.64%+144.98%+213.97%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
0.00%+0.49%+0.44%+24.71%+29.29%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Azenta, Inc. stock logo
AZTA
Azenta
2.43
Hold$41.2023.61% Upside
CryoPort, Inc. stock logo
CYRX
CryoPort
2.78
Moderate Buy$18.0021.46% Upside
Personalis, Inc. stock logo
PSNL
Personalis
2.22
Hold$14.25-1.72% Downside
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
1.88
Reduce$17.25-5.99% Downside

Current Analyst Ratings Breakdown

Latest SLP, PSNL, AZTA, and CYRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$12.00 ➝ $16.00
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$21.00
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $19.00
8/5/2026
Azenta, Inc. stock logo
AZTA
Azenta
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$33.00 ➝ $37.00
8/3/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
7/24/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$17.00 ➝ $25.00
7/21/2026
Personalis, Inc. stock logo
PSNL
Personalis
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
7/20/2026
Personalis, Inc. stock logo
PSNL
Personalis
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold$16.25
7/20/2026
Personalis, Inc. stock logo
PSNL
Personalis
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$11.00 ➝ $16.25
7/20/2026
Personalis, Inc. stock logo
PSNL
Personalis
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
7/17/2026
Personalis, Inc. stock logo
PSNL
Personalis
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 8/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Azenta, Inc. stock logo
AZTA
Azenta
$613.81M2.50$1.89 per share17.68$37.67 per share0.88
CryoPort, Inc. stock logo
CYRX
CryoPort
$176.18M4.26N/AN/A$9.19 per share1.61
Personalis, Inc. stock logo
PSNL
Personalis
$69.65M21.80N/AN/A$2.94 per share4.93
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$82.06M4.52$1.43 per share12.80$6.20 per share2.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Azenta, Inc. stock logo
AZTA
Azenta
-$55.76M-$2.76N/AN/AN/A-20.63%1.18%0.97%N/A
CryoPort, Inc. stock logo
CYRX
CryoPort
$78.30M-$0.90N/AN/AN/A-20.05%-7.20%-4.30%N/A
Personalis, Inc. stock logo
PSNL
Personalis
-$81.27M-$1.09N/AN/AN/A-153.84%-46.47%-35.30%N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-$64.72M$0.4045.88N/AN/A9.88%13.50%12.45%10/29/2026 (Estimated)

Latest SLP, PSNL, AZTA, and CYRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
CryoPort, Inc. stock logo
CYRX
CryoPort
-$0.1933-$0.20-$0.0067-$0.20$48.18 million$48.97 million
8/4/2026Q3 2026
Azenta, Inc. stock logo
AZTA
Azenta
$0.1138$0.16+$0.0462$0.05$149.31 million$161.18 million
8/4/2026Q2 2026
Personalis, Inc. stock logo
PSNL
Personalis
-$0.2633-$0.30-$0.0367-$0.30$16.69 million$22.36 million
7/9/2026Q3 2026
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.2325$0.30+$0.0675$0.18$20.90 million$21.89 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Azenta, Inc. stock logo
AZTA
Azenta
$0.100.30%-100.00%N/A N/A
CryoPort, Inc. stock logo
CYRX
CryoPort
N/AN/AN/AN/AN/A
Personalis, Inc. stock logo
PSNL
Personalis
N/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.241.31%-100.00%60.00%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Azenta, Inc. stock logo
AZTA
Azenta
N/A
2.50
2.21
CryoPort, Inc. stock logo
CYRX
CryoPort
N/A
2.08
1.98
Personalis, Inc. stock logo
PSNL
Personalis
N/A
5.28
5.08
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
5.54
5.54

Institutional Ownership

CompanyInstitutional Ownership
Azenta, Inc. stock logo
AZTA
Azenta
99.08%
CryoPort, Inc. stock logo
CYRX
CryoPort
92.90%
Personalis, Inc. stock logo
PSNL
Personalis
61.91%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%

Insider Ownership

CompanyInsider Ownership
Azenta, Inc. stock logo
AZTA
Azenta
10.90%
CryoPort, Inc. stock logo
CYRX
CryoPort
9.50%
Personalis, Inc. stock logo
PSNL
Personalis
4.20%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Azenta, Inc. stock logo
AZTA
Azenta
3,00046.09 million41.07 millionOptionable
CryoPort, Inc. stock logo
CYRX
CryoPort
1,18650.65 million45.84 millionOptionable
Personalis, Inc. stock logo
PSNL
Personalis
400104.72 million100.32 millionOptionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
16020.23 million16.36 millionOptionable

Recent News About These Companies

Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
August 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3340484/0/en/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures.html
Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of "Reduce" by Analysts
August 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30943563
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of "Reduce" from Analysts
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-inc-nasdaqslp-receives-consensus-recommendation-of-reduce-from-analysts-2026-08-06/
Simulations Plus (NASDAQ:SLP) Stock Price Passes Above 200-Day Moving Average - Here's Why
August 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-nasdaqslp-stock-price-passes-above-200-day-moving-average-heres-why-2026-08-04/
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
July 30, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260730539938/en/simulations-plus-investor-alert-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-proposed-sale-of-simulations-plus-inc.---slp/
Simulation Plus, Inc. Securities Fraud Investigation - Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws
July 29, 2026  |  newsfilecorp.comN
SLP Shareholder Alert: Robbins LLP is Investigating Allegations that the Officers and Directors of Simulation Plus, Inc., Violated Securities Laws and Breached Fiduciary Duties to Shareholders
July 28, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/slp-shareholder-alert-robbins-llp-is-investigating-allegations-that-the-officers-and-directors-of-simulation-plus-inc-violated-securities-laws-and-breached-fiduciary-duties-to-shareholders-302837099.html
Simulation Plus, Inc. (NASDAQ: SLP) Investors Should Contact Robbins LLP for Information About Investigation
July 27, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260727420213/en/simulation-plus-inc.-nasdaq-slp-investors-should-contact-robbins-llp-for-information-about-investigation/
Simulations Plus, Inc. $SLP Stock Position Boosted by First Light Asset Management LLC
July 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-simulations-plus-inc-slp-stock-position-boosted-by-first-light-asset-management-llc-2026-07-27/
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
July 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/24/3333033/0/en/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures.html
Simulations Plus (NASDAQ:SLP) Share Price Crosses Above 200-Day Moving Average - Time to Sell?
July 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-nasdaqslp-share-price-crosses-above-200-day-moving-average-time-to-sell-2026-07-21/
Simulations Plus: The Potential Little Spread Is Not Worth The Risk For New Money, Hold
July 20, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4923295-simulation-plus-stock-potential-spread-not-worth-the-risk-hold
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
July 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/13/3326261/0/en/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures.html
Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Recommendation of "Hold" from Brokerages
July 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/simulations-plus-inc-nasdaqslp-receives-average-recommendation-of-hold-from-brokerages-2026-07-12/
Simulations Plus, Inc. Q3 2026 Earnings
July 9, 2026  |  247wallst.comhttps://247wallst.com/cards/simulations-plus-inc-q3-2026-earnings-slp-01kx47y2hkyfz7jphb20t120tk
Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
July 9, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260709321948/en/simulations-plus-reports-third-quarter-fiscal-2026-financial-results/
John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock
July 9, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-slp-insider-buying-and-selling-2026-07-09/
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
July 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/08/3324198/0/en/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures.html
Simulations Plus (NASDAQ:SLP) Director Sells 4,177 Shares of Stock
July 7, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-slp-insider-buying-and-selling-2026-07-07/
Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
July 6, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/johnson-fistel-investigates-simulations-plus-following-revenue-guidance-cut-and-accounting-disclosures-302818503.html
Shareholder Alert: Ademi LLP investigates whether Simulations Plus, Inc. is obtaining a Fair ...
July 2, 2026  |  caledonianrecord.comC

New MarketBeat Followers Over Time

Media Sentiment Over Time

Azenta stock logo

Azenta NASDAQ:AZTA

$33.33 +1.29 (+4.03%)
As of 04:00 PM Eastern

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

CryoPort stock logo

CryoPort NASDAQ:CYRX

$14.82 -0.30 (-1.98%)
As of 04:00 PM Eastern

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Personalis stock logo

Personalis NASDAQ:PSNL

$14.50 +0.34 (+2.40%)
As of 04:00 PM Eastern

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.

Simulations Plus stock logo

Simulations Plus NASDAQ:SLP

$18.35 +0.03 (+0.16%)
As of 04:00 PM Eastern

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas